BIOMAT Database Logo BIOMAT Database Logo

Class II antiarrhythmic agents. 1988

J W Upward, and D G Waller, and C F George
Clinical Pharmacology Group, University of Southampton, U.K.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac

Related Publications

J W Upward, and D G Waller, and C F George
Sotalol versus class I and II antiarrhythmic agents.
June 1990, Cardiovascular drugs and therapy,
J W Upward, and D G Waller, and C F George
Development of class III antiarrhythmic agents.
January 1992, Journal of cardiovascular pharmacology,
J W Upward, and D G Waller, and C F George
Antiarrhythmic agents. II. Therapeutic considerations.
January 1973, Drugs,
J W Upward, and D G Waller, and C F George
A new class of antiarrhythmic-defibrillatory agents.
November 2001, Bioorganic & medicinal chemistry letters,
J W Upward, and D G Waller, and C F George
Class III antiarrhythmic agents: the next wave.
January 1997, Pharmacotherapy,
J W Upward, and D G Waller, and C F George
Proarrhythmic effects of class III antiarrhythmic agents.
December 1993, Cardiovascular research,
J W Upward, and D G Waller, and C F George
Haemodynamic effects of class I antiarrhythmic agents.
January 1985, Drugs,
J W Upward, and D G Waller, and C F George
Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
August 1991, Cardiovascular drugs and therapy,
J W Upward, and D G Waller, and C F George
Propafenone shows class Ic and class II antiarrhythmic effects.
April 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology,
J W Upward, and D G Waller, and C F George
Initiation and monitoring of class III antiarrhythmic agents.
December 2003, Journal of cardiovascular electrophysiology,
Copied contents to your clipboard!